← Back to patent-cliff list
Lotilaner
Tier C — Watch / tradeLotilaner
Elanco Tiergesundheit Ag
Originator
2023
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：mites GABA-gated chloride channel
Brand：XDEMVY
Indications (approved)：蠕形螨性睑缘炎
Regional status
US
Approved
2023-07-24
EU
-
China
Approved
2026-03-17
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Lotilaner?
Approved indications include: 蠕形螨性睑缘炎.
When does the Lotilaner patent expire?
No public expiry year is available for Lotilaner yet; this page updates once verified.
How do I get a quote for Lotilaner intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27